Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Crispr Therapeutics AG

NASDAQ: CRSP · Life Sciences · 9 alerts · CIK 1674416

Share price
$40.37Close, Nov 16
Market cap
$3.92B
Shares outstanding
97MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Crispr Therapeutics AG filings on SEC EDGAR ↗

4:11 PM ET 8-K
Executive Compensation

Crispr Therapeutics Executive Compensation

CRISPR Therapeutics promoted Andrew J. Silver to Chief Financial Officer, effective October 19, 2026. Under his new employment agreement, Mr. Silver will receive an annual base salary of $515,000, a target bonus of 45%, and a one-time grant of 25,000 restricted stock units vesting over two years.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.